Literature DB >> 6309446

CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque.

G M Georgiou, D M Roberton, W M Ellis, B J Shen, H Ekert, C S Hosking.   

Abstract

This study compares the efficiency of different methods of separation of human bone marrow in vitro prior to transplantation. Separation on Ficoll-paque resulted in a median recovery of 11.3 X 10(4) CFU-c/10(9) nucleated cells harvested. The recovery from the major CFU-c containing fraction following separation on a discontinuous Percoll gradient was 10.8 X 10(4) CFU-c/10(9) nucleated cells. The CFU-c recovered from Percoll were contained in a smaller number of cells, resulting in enrichment for CFU-c of 1.6 times that of Ficoll-paque. Further CFU-c enrichment to approximately three times that of Ficoll-paque separation was possible by treatment of Percoll fractionated cells with soybean agglutinin (SBA). However this caused an overall loss of 67% of CFU-c. Cells remaining after SBA treatment of the CFU-c containing Percoll fraction had increased spontaneous DNA synthesis and decreased PHA responses. There was no significant change in the mixed lymphocyte reaction in comparison with Ficoll-paque.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309446      PMCID: PMC1535667     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Separation of human bone marrow cells in density gradients of polyvinylpyrrolidone coated silica gel (Percoll).

Authors:  T Olofsson; I Gärtner; I Olsson
Journal:  Scand J Haematol       Date:  1980-03

2.  Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin.

Authors:  Y Reisner; N Kapoor; R J O'Reilly; R A Good
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

3.  Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells.

Authors:  M A Moore; H E Broxmeyer; A P Sheridan; P A Meyers; N Jacobsen; R J Winchester
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

4.  The myeloid progenitor cell--its value in predicting hematopoietic recovery after autologous bone marrow transplantation.

Authors:  G Spitzer; D S Verma; R Fisher; A Zander; L Vellekoop; J Litam; K B McCredie; K A Dicke
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

5.  A reliable technique for making permanent preparations of bone marrow cultures.

Authors:  W M Ellis; B Dobrostanski; C M Paton; W Aitken
Journal:  Pathology       Date:  1980-10       Impact factor: 5.306

6.  Quantitation of lymphocyte proliferative response to allogeneic cells and phytohemagglutinin by flow cytofluorometry. II. Comparison with [14C]thymidine incorporation.

Authors:  J D Braunstein; M R Melamed; T K Sharpless; J A Hansen; B Dupont; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1976-05

7.  A technique for the separation and cryopreservation of myeloid stem cells from human bone marrow.

Authors:  J R Wells; A Sullivan; M J Cline
Journal:  Cryobiology       Date:  1979-06       Impact factor: 2.487

8.  Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; B Dupont; R A Good; R J O'Reilly
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

9.  A satisfactory quantitative test of lymphocyte response to phytohaemagglutinin for the definition of normal control values and recognition of immunological defects.

Authors:  M G Fitzgerald
Journal:  J Clin Pathol       Date:  1972-02       Impact factor: 3.411

10.  Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone.

Authors:  D A Vallera; C C Soderling; G J Carlson; J H Kersey
Journal:  Transplantation       Date:  1981-03       Impact factor: 4.939

View more
  1 in total

1.  The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.

Authors:  A Nagler; S Morecki; S Slavin
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.